MARKET

ANTX

Anthem
ANTX
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
0.0000
0.0444
0.1039
3,905,278,342.53
ANTX Receives FDA Clearance To Begin Epetraborole Trial In M. Abscessus Lung Disease
NASDAQ · 01/12 15:16
The FDA Clears Oregon Health & Science University's Investigational New Drug Application To Proceed With Investigator-Initiated Trial Of AN2 Therapeutics' Epetraborole For Mycobacterium Abscessus Lung Disease, Patient Enrollment To Start In Q1 2026
Benzinga · 01/12 12:10
*AN2 Therapeutics Projects Existing Cash, Cash Equivalents and Investments Will Sustain Ops Into 2028
Dow Jones · 11/12/2025 21:11
*AN2 Therapeutics Advancing Phase 1 Program in Chagas Disease; Phase 2 Planning Underway >ANTX
Dow Jones · 11/12/2025 21:10
*AN2 Therapeutics 3Q Loss/Shr 31c >ANTX
Dow Jones · 11/12/2025 21:01
*AN2 Therapeutics 3Q Loss $9.35M >ANTX
Dow Jones · 11/12/2025 21:01
Press Release: AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
Dow Jones · 11/12/2025 21:01
AN2 Therapeutics Announces Collaboration Agreement With GSK To Develop New Therapies For TB
Benzinga · 11/10/2025 12:11
More

Webull offers Anthem stock information, including NYSE: ANTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANTX stock methods without spending real money on the virtual paper trading platform.